Hyperliquid Strategies, Inc. (PURR)
8.31
-0.39
(-4.48%)
USD |
NASDAQ |
Nov 16, 16:00
8.22
-0.09
(-1.08%)
After-Hours: 20:00
Hyperliquid Strategies EPS Diluted (Quarterly) : 2.542 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 2.542 |
| June 30, 2026 | 2.102 |
| March 31, 2026 | 1.011 |
| Date | Value |
|---|---|
| December 31, 2025 | -2.454 |
| September 30, 2025 | -0.1081 |
| June 30, 2025 | -0.0048 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Strive, Inc. (United States) | 5.244 |
| Meridian Holdings, Inc. (California) | 0.00 |
| ACADIA Pharmaceuticals, Inc. | 0.305 |
| Agenus, Inc. | 0.0183 |
| Alnylam Pharmaceuticals, Inc. | 15.72 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 620.60M |
| Revenue (Quarterly) | 12.25M |
| Total Expenses (Quarterly) | -608.35M |
| Enterprise Value | 2.010B |
| Earnings Yield | 38.52% |
| Operating Earnings Yield | 0.01% |
| Normalized Earnings Yield | -22.69 |